ze6ZYBD9tOH6uoFLVNBJ6Ch0OfV0xM7VeBcMqbsDCbo4v2nxIvQbMygBfs6w
Current position: Home >> Scientific Research >> Research Projects

抗血管生成药物对NSCLC肿瘤干细胞的影响及其机制研究

Hits:

Project Name:抗血管生成药物对NSCLC肿瘤干细胞的影响及其机制研究

Institution:山东大学齐鲁医院

Leading Scientist:王秀问

Supported by:2013年济南市高校院所自主创新计划

Nature of Project:纵向

Project Level:Prefectural (City, Prefecture) Level

Project Participants:王秀问

Project Number:kyxm-48683

Project Approval Number:201303046

Date of Project Approval:2013-01-01

Scheduled Completion Time:2015-12-31

Date of Project Completion:2015-12-31

Date of Project Initiation:2013-01-01

Release Time:2020-03-20

Prev One:Wnt/β-catenin信号通路在抗血管治疗所致非小细胞肺癌恶性表型增强中的作用及机制探讨

Next One:FoxM1转录因子在肺腺癌干细胞特性维持中的作用及其与Wnt/β-catenin信号通